Objective: To summarize the FDA approval of cemdisiran for adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis, the supporti
The FDA approved cemdisiran, the first siRNA therapy for adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.
Cemdisiran targets messenger RNA encoding complement component 5 and is administered subcutaneously at 567 mg every 3 months by a health care provider.
In the phase 3 NIMBLE trial, cemdisiran improved MG-ADL scores by 4.5 points at week 24, compared with 2.2 points with placebo.
Cemdisiran improved QMG scores by 4.2 points at week 24, compared with 1.5 points with placebo.
Cemdisiran carries a boxed warning for serious meningococcal infections and is available only through a restricted Risk Evaluation and Mitigation Strategy program.
Objective: To develop and evaluate a quantitative lateral flow immunoassay for measuring plasma soluble AXL (sAXL) as a potential aid to pancreatic ductal adeno
Researchers developed a quantitative colorimetric lateral flow immunoassay to measure soluble AXL (sAXL) in plasma as a potential aid to pancreatic ductal adenocarcinoma diagnosis.
The assay uses capture and biotinylated detection antibodies, with anti-biotin gold nanoparticles generating a visible signal.
In a cohort of 20 patients with pancreatic ductal adenocarcinoma and 20 healthy controls, the assay detected higher sAXL concentrations and statistically differentiated the groups.
The study was an early clinical evaluation and did not assess whether the assay distinguishes pancreatic cancer from chronic pancreatitis or other relevant diseases.
The findings do not establish the assay for screening or as a replacement for imaging, histopathology, cytology, or laboratory ELISA; larger independent studies are needed.
Objective: The article profiles Michael Marty’s research on membrane proteins and lipids, his views on emerging analytical technologies and graduate training, a
Michael Marty’s research examines the lipids surrounding membrane proteins and how those lipids affect protein structure and function.
His group develops mass spectrometry methods to study protein structure and interactions.
Marty says advances in molecular biology, separations, and mass spectrometry have made previously impractical research projects possible.
He expects AI-guided protein design and custom gene synthesis to enable more analytical applications using bespoke proteins.
Marty identifies training the next generation as analytical science’s biggest challenge, citing shrinking graduate programs and barriers facing students.
Objective: To examine how sensation-seeking and impulsivity relate to reward-guided choices and responses to uncertain sensory stimulation. Approach: Experiment
In a preregistered online experiment, higher sensation-seeking was associated with greater choice variability and lower reward performance.
Participants generally avoided options with more uncertain visual stimulation, but higher sensation-seeking was associated with weaker uncertainty avoidance.
Higher impulsivity was associated with stronger uncertainty avoidance, contrasting with sensation-seeking; the difference between these associations was statistically significant.
Exploratory analyses found that sensation-seeking’s association with uncertainty avoidance depended on how participants weighted expected stimulation.
The study combined reanalysis of data from 73 adults with an online experiment that included 527 adults in its final analysis.
Objective: Develop and evaluate a composite index for tracking oxidative deterioration in hazelnuts using volatile aldehydes measured by HS-SPME-GC-MS. Approach
The Rancidity Score Index (RSI) combines concentrations of hexanal, heptanal, octanal, and nonanal measured by HS-SPME-GC-MS into a score from 0 to 100.
Researchers developed the RSI using 312 hazelnut samples from the 2020, 2021, and 2023 harvests and evaluated it on 104 samples from the withheld 2022 crop year.
The study included 416 industrial samples spanning Italian and Turkish hazelnuts, multiple cultivars and post-harvest conditions, and storage observations across 24 months.
RSI scores rose more continuously during atmospheric-air storage, while vacuum packaging at 5 °C limited increases for 9 months before scores rose moderately.
A preliminary comparison of 30 samples found strong agreement between RSI values from mass spectrometry and flame-ionization detection, although heptanal agreement was poorer.
Baptist Health Herbert Wertheim Cancer Institute became Memorial Sloan Kettering Cancer Center’s only Care Partner in Florida after an extensive evaluation.
The Institute aligned with MSK’s Standards of Care™ after review of its clinical infrastructure, care processes, and clinical outcomes.
The partnership expands access to MSK clinical advances, research and clinical trials, and physician education while patients continue care with local oncologists.
Wertheim and MSK physicians will plan and conduct trials in medical oncology, radiation oncology, and surgery, with streamlined second-opinion referrals.
A $12.5 million gift from Kenneth C. Griffin supports the expanded relationship, which builds on the Institute’s 9-year participation in the MSK Cancer Alliance.
In 10 healthy volunteers, researchers tested collagen–PMMA scaffold injections followed by autologous sole or scalp fibroblasts, with vehicle-treated sites as controls.
Sole fibroblasts with the scaffold increased skin firmness, epidermal thickness, papillary elastin, collagen content, and collagen fiber length versus vehicle.
The scaffold did not significantly enhance fibroblast-associated epidermal thickening compared with fibroblast therapy alone, and no significant scaffold–fibroblast interaction was found.
Scaffold-treated tissue showed stromal remodeling and immune and endothelial cell recruitment, including at vehicle-treated sites, with persistent PMMA microspheres and localized foreign body response
The study was limited by its small sample, historical comparison cohort, exploratory molecular analyses, and 5-month follow-up; it did not assess functional skin protection.
Objective: The article examines how rising real yields and biotech financing conditions affect drug-development investment, and how China’s clinical-stage pipel
Objective: To compare estimated primary-prevention aspirin eligibility using PREVENT-ASCVD risk thresholds with eligibility based on the USPSTF’s PCE threshold
Objective: The article reports findings from a KFF survey on the prevalence of unpaid caregiving, caregivers’ time commitments and tasks, and reported effects o
A KFF survey found that 29% of U.S. adults provided unpaid care to a friend or family member in the past 12 months.
Women accounted for 57% of unpaid caregivers, and 53% of caregivers were aged 50 or older.
Caregivers provided a median of 5 hours of care weekly; 23% spent more than 15 hours per week.
Overall, 66% of caregivers reported stress or worry, 35% reported worse mental health, 29% worse physical health, and 25% financial strain.
Among caregivers providing more than 15 hours of care weekly, 81% reported stress or worry, 51% worse mental health, 47% worse physical health, and 41% financial strain.
Objective: Characterize real-world psychological assessment practices before and after metabolic bariatric surgery (MBS) among adolescents in the United States.
Objective: The article recaps AARC Congress 2026 in New Orleans, including its educational programming, professional activities, and community events. Approach:
Objective: Correct the investigator list in the LITMUS Imaging Study of MASLD biomarkers article. Approach: Correction: The HTML and PDF versions were updated t
A correction to the LITMUS Imaging Study of MASLD biomarkers was published online on July 24, 2026.
The correction concerns a Nature Medicine article with DOI 10.1038/s41591-026-04496-2.
Joanne Verheij was added to the LITMUS Consortium Investigators list.
Verheij is affiliated with the Department of Pathology at Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, in Amsterdam, The Netherlands.
Verheij’s name was absent from the initially published article and is now included in its HTML and PDF versions.
Objective: To assess associations between masked hypertension phenotypes identified by ambulatory blood pressure monitoring (ABPM) and left ventricular hypertro
This cross-sectional study analyzed 2022 Massachusetts claims for 151,194 children aged 1 to 4 years enrolled in Medicaid or private insurance.
Overall, 40.8% of children lived in areas with community water fluoridation (CWF), and prescription fills were more common without CWF than with it (14.5% vs 0.8%).
Adjusted prescription-fill probabilities were 14.2% without CWF and 0.8% with CWF (P < .001).
Without CWF, adjusted fill probabilities were higher for children with Medicaid than for those with private insurance; with CWF, probabilities did not differ significantly by insurance type.
The authors noted that single-state data, possible CWF misclassification, and unavailable data on supplements purchased without insurance may have limited the findings.
Objective: To clarify what the authors’ histological findings establish about proposed anatomical pathways for anal fistulas. Approach: Anatomical findings: The
The intersphincteric region was structurally heterogeneous and compartmentalized, not a uniform anatomical plane.
At mid-height of the internal anal sphincter, the dense longitudinal muscle component ended, leaving a lower compartment dominated by loose muscle and connective tissue.
Branching loose longitudinal muscle fibers extended through gaps between external anal sphincter bundles, and the levator ani had a layered organization.
Normal cadaveric specimens did not establish the Garg fascia, outer-sphincteric space, or a pathway corresponding to a RIFIL fistula.
The authors propose clinicopathological studies combining oriented tissue analysis, preoperative MRI, and intraoperative fistula mapping to clarify fistula pathways.
Objective: To assess how Medicare price negotiation was associated with 30-day out-of-pocket costs for high-cost cardiovascular medications and whether generic
This repeated cross-sectional study used a difference-in-differences approach to assess Medicare plan-level out-of-pocket costs before and after price negotiation began.
The analysis included 6215 Medicare drug coverage plans and compared negotiated cardiovascular medications with nonnegotiated PCSK9 inhibitors and ticagrelor.
Negotiation was associated with a $56.63 decrease in 30-day out-of-pocket costs for medications without a generic alternative (95% CI, $55.48-$57.78).
For medications with a generic alternative, negotiation was associated with a $7.46 decrease in 30-day out-of-pocket costs (95% CI, $6.05-$8.78).
The study covered the first year of negotiation and plan-level costs only, excluding beneficiary-level data, clinical outcomes, and other contemporaneous policy changes.
Objective: The article examines the objective, findings, and clinical context described in FDA approves first NPC survival treatment. Approach: Approval populat
The FDA approved adrabetadex (Lembaz) as the first treatment shown to reduce mortality risk in Niemann-Pick disease type C.
Approval covers adults and children weighing at least 7 kg whose neurological symptoms began before age 6.
In a nonrandomized analysis, median overall survival was 102 months with adrabetadex and 59 months in matched external controls, with a 55% lower relative risk of death.
Adrabetadex carries a boxed warning for hearing impairment, including permanent hearing loss, and requires audiological evaluations before treatment and during dose escalation.
Adrabetadex is administered intrathecally every 2 weeks by or under the supervision of a clinician experienced in lumbar punctures.